Sophiris Bio Inc. buy krebskrebs
Start price
03.05.20
/
50%
€0.20
Target price
04.11.21
€0.30
Performance (%)
-91.25%
End price
05.11.21
-
Summary
This prediction is currently being closed. Massive losses of -91.25% have been the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sophiris Bio Inc. | - | - | - | - |
| iShares Core DAX® | -0.975% | -4.716% | 4.787% | 53.022% |
| iShares Nasdaq 100 | 1.163% | 1.881% | 20.234% | 95.411% |
| iShares Nikkei 225® | -1.593% | -5.385% | 31.353% | 54.646% |
| iShares S&P 500 | -0.278% | 0.327% | 13.911% | 66.550% |
Comments by krebskrebs for this prediction
In the thread Sophiris Bio Inc. diskutieren
In the thread Trading Sophiris Bio Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten